PONIARD PHARMACEUTICALS (PARD) 7.98 $0.09 (1.14%) 03:05PM (15 mins delay)

Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer

Jun 19, 2009 - 8:36 AM EDT

Michael Becker submits:

Prostate cancer is the most common type of cancer found in American men, other than skin cancer. In 2009, the American Cancer Society estimates that there will be nearly 200,000 new cases of prostate cancer in the United States and that about 27,000 men will die from the disease. It is estimated that there are more than 2 million American men currently living with prostate cancer.

As noted in our June 1, 2009 article, investors appear to be gravitating towards biotechnology companies working in the field of prostate cancer. Consider the following:

Complete Story »

Source: Seeking Alpha (Jun 19, 2009 - 8:36 AM EDT)